Based on the mutations of various genes in the two MMP score groups and the corresponding prognoses, TTN, TP53, MUC16, and LRP1B genes might play important roles in influencing the outcomes and clinicopathological features of GC. The gene discussed is TP53; the disease is gastric cancer.